Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue CEUS for Breast Lesion Characterization
NCT02177045Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Oct 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sulfur hexafluoride in breast cancer, sponsored by Rambam Health Care Campus. Primary endpoint: Tumor vascularization at 1 year. Status: unknown.
02
Drugs
sulfur hexafluoride
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02177045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177045.